CBD

Filter Results

Displaying 13-22 of 22 results

Sort By

Policy & Research

2017 Kansas Legislative Recap

1 Min Read

Sep 18, 2017

alt=""

Policy & Research

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas

1 Min Read

Mar 16, 2017

Tatiana Y. Lin, M.A., KHI Senior Analyst and Strategy Team Leader, provided neutral testimony on House Bill 2152 to the House Committee on Health and Human Services. The bill would, among other things, authorize hemp treatments for certain medical conditions.

Policy & Research

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas

1 Min Read

Feb 20, 2017

alt=""

Policy & Research

2017 Kansas Legislative Preview

17 Min Read

Jan 04, 2017

alt=""

Policy & Research

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (HB 2049)

1 Min Read

Jan 22, 2016

Tatiana Lin, senior analyst and strategy team leader, presented neutral testimony to the Senate Committee on Corrections and Juvenile Justice for House Bill 2049.

Policy & Research

2016 Kansas Legislative Preview

15 Min Read

Jan 06, 2016

alt=""

Policy & Research

Potential Health Effects of Legalizing Medical Marijuana in Kansas

1 Min Read

Sep 28, 2015

alt=""

Policy & Research

Issue Brief - 2015 Kansas Legislative Recap

12 Min Read

Sep 08, 2015

alt=""

Policy & Research

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (HB 2282)

1 Min Read

Feb 17, 2015

Tatiana Lin, KHI Senior Analyst and Stretegy Team Leader presented neutral testimony on Feb. 17, 2015 to the Health and Human Services Committee on HB 2282.

Policy & Research

Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (in progress)

1 Min Read

Jan 23, 2015

Tatiana Lin testifying before senate public health and welfare committee

2